IL31 and Alzheimer disease: In a mouse model, IL-31 was demonstrated to induce skin changes similar to those that occur in AD, characterized by epidermal hyperplasia, acanthosis, hyperkeratosis, and an increase in the number of inflammatory cells and mast cells [183].